Form 4: Medpace Director Converts RSUs to Boost Stock Holdings

Medpace Holdings Director Cornelius P. McCarthy III converted 49 restricted stock units into common stock on September 30, 2025, increasing his direct beneficial ownership to 10,246 shares.

Summary

• Director Cornelius P. McCarthy III converted 49 restricted stock units (RSUs) into common stock.
• The transaction occurred on September 30, 2025, as part of a pre-scheduled plan.
• Each restricted stock unit represents a contingent right to receive one share of Medpace Holdings, Inc. common stock.
• Following this conversion, McCarthy III directly beneficially owns 10,246 shares of Medpace Holdings, Inc. common stock.
• The converted RSUs were part of an original grant of 198 units on November 29, 2024, which vest in four approximately equal installments.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-scheduled conversion of restricted stock units by a director, which is an expected part of executive compensation and ownership, thus having a neutral impact on sentiment.

Positives

• Director Cornelius P. McCarthy III increased his direct beneficial ownership of Medpace Holdings, Inc. common stock by 49 shares, demonstrating continued alignment with shareholder interests.

Future Outlook

Remaining restricted stock units from the November 29, 2024 grant are scheduled to vest in approximately equal installments, with the final installment on December 31, 2025.

Industry Context

This is a routine insider transaction related to executive compensation and does not directly reflect broader industry trends or competitive positioning.

Related Party Transactions

• The conversion of restricted stock units into common stock is part of a pre-existing equity compensation plan for Director Cornelius P. McCarthy III, a standard related-party transaction for executive compensation.

Stakeholder Impact

• Shareholders may view the increase in direct beneficial ownership by a director as a positive signal of alignment with company performance and long-term interests.

Next Steps

• The remaining restricted stock units from the November 29, 2024 grant are scheduled to vest on December 31, 2025.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled conversion of restricted stock units by a director, which is an expected part of executive compensation. It does not provide new information that would alter the fundamental investment thesis for Medpace Holdings, Inc., warranting a 'hold' recommendation based solely on this filing.

Keywords

Medpace Holdings, MEDP, Form 4, Insider Transaction, Restricted Stock Units, Director Ownership, Equity Compensation, Cornelius P. McCarthy III